4//SEC Filing
NEWMAN MARY 4
Accession 0001209191-17-050294
CIK 0001628738other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:17 PM ET
Size
8.9 KB
Accession
0001209191-17-050294
Insider Transaction Report
Form 4
NEWMAN MARY
SVP, Regulatory Affairs
Transactions
- Sale
Common Stock
2017-08-24$20.00/sh−10,000$200,000→ 0 total - Exercise/Conversion
Common Stock
2017-08-24$2.19/sh+10,000$21,900→ 10,000 total - Exercise/Conversion
Stock Option (right to buy)
2017-08-24−10,000→ 43,817 totalExercise: $2.19Exp: 2025-02-04→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F2]The option vested as to 25% of the total shares on October 1, 2015, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on October 1, 2018, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
Audentes Therapeutics, Inc.
CIK 0001628738
Entity typeother
Related Parties
1- filerCIK 0001679132
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 4:17 PM ET
- Size
- 8.9 KB